1. Higdon JV, Frei B (2003) Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 43:89–143

2. McKay DL, Blumberg JB (2002) The role of tea in human health: an update. J Am Coll Nutr 21:1–13

3. Nie G, Jin C, Cao Y et al (2002) Distinct effects of tea catechins on 6-hydroxydopamine-induced apoptosis in PC12 cells. Arch Biochem Biophys 397:84–90

4. Guo S, Bezard E, Zhao B (2005) Protective effect of green tea polyphenols on the SH-SY5Y cells against 6-OHDA induced apoptosis through ROS-NO pathway. Free Radic Biol Med 39:682–695

5. Guo S, Yan J, Yang T et al (2007) Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson’s disease through inhibition of ROS-NO pathway. Biol Psychiatry 62:1353–1362

6. Yan J, Zhao Y, Suo S et al (2012) Green tea catechins ameliorate adipose insulin resistance by improving oxidative stress. Free Radic Biol Med 52:1648–1657

7. Yan J, Zhao Y, Zhao B (2013) Green tea catechins prevent obesity through modulation of peroxisome proliferator-activated receptors. Sci China Life Sci 56:804–810

8. Eschenauer G, Sweet BV (2006) Pharmacology and therapeutic uses of Theanine. Am J Health Syst Pharm 63:28–30

9. Yan J, Di X, Liu C et al (2010) The cessation and detoxification effect of tea filters on cigarette smoke. Sci China Life Sci 53:533–541

10. Di X, Yan J, Zhao Y et al (2012) L-Theanine inhibits nicotine-induced dependence via regulation of the nicotine acetylcholine receptor-dopamine reward pathway. Sci China Life Sci 55:1064–1074

11. Nathan PJ, Lu K, Gray M et al (2006) The neuropharmacology of L-Theanine(N-ethyl-L-glutamine): a possible neuroprotective and cognitive enhancing agent. J Herb Pharmacother 6:21–30

12. Sakato Y (1949) The chemical constituents of tea; III. A new amide theanine. Nippon Nogeikagaku Kaishi 23:262–267

13. Cartwright RA, Roberts EAH, Wood DJ (1954) Theanine, an amino-acid n-ethyl amide present in tea. J Sci Food Agric 5:597–599

14. Yokogoshi H, Kobayashi M, Mochizuki M et al (1998) Effect of theanine, r-glutamylethylamide, on brain monoamines and striatal dopamine release in conscious rats. Neurochem Res 23:667–673

15. Juneja LR, Chu DC, Okubo T et al (1999) L-Theanine—a unique amino acid of green tea and its relaxation effect in humans. Trends Food Sci Tech 10:199–204

16. Borzelleca JF, Peters D, Hall W (2006) A 13-week dietary toxicity and toxicokinetic study with L-Theanine in rats. Food Chem Toxicol 44:1158–1166

17. Ito K, Nagato Y, Aoi N et al (1998) Effects of L-Theanine on the release of alphabrain waves in human volunteers. Nippon Nogeikagaku Kaishi 72:153–157

18. Kimura K, Ozeki M, Juneja LR et al (2007) L-Theanine reduces psychological and physiological stress responses. Biol Psychol 74:39–45

19. Kakuda T, Nozawa A, Unno T et al (2000) Inhibiting effects of theanine on caffeine stimulation evaluated by EEG in the rat. Biosci Biotechnol Biochem 64:287–293

20. Jang HS, Jung JY, Jang IS et al (2012) L-Theanine partially counteracts caffeine-induced sleep disturbances in rats. Pharmacol Biochem Behav 101:217–221

21. Kakuda T, Nozawa A, Sugimoto A et al (2002) Inhibition by theanine of binding of [3H]AMPA, [3H] kainate, and [3H]MDL 105,519 to glutamate receptors. Biosci Biotechnol Biochem 66:2683–2686

22. Yamada T, Terashima T, Okubo T et al (2005) Effects of theanine, r-glutamylethylamide, on neurotransmitter release and its relationship with glutamic acid neurotransmission. Nutr Neurosci 8:219–226

23. Yokogoshi H, Mochizuki M, Saitoh K (1998) Theanine-induced reduction of brain serotonin concentration in rats. Biosci Biotechnol Biochem 62:816–817

24. Kimura R, Murata T (1971) Influence of alkylamides of glutamic acid and related compounds on the central nervous system. I. Central depressant effect of theanine. Chem Pharm Bull (Tokyo) 19:1257–1261

25. Kakuda T et al (2002) Neuroprotective effects of the green tea components theanine and catechins. Biol Pharm Bull 25:1513–1518

26. Egashira N, Hayakawa K, Mishima K et al (2004) Neuroprotective effect of gamma-glutamylethylamide (theanine) on cerebral infarction in mice. Neurosci Lett 363:58–61

27. Egashira N, Ishigami N, Pu F et al (2008) Theanine prevents memory impairment induced by repeated cerebral ischemia in rats. Phytother Res 22:65–68

28. Walsh DM, Selkoe DJ (2007) A beta oligomers—a decade of discovery. J Neurochem 101:1172–1184

29. Snyder EM, Nong Y, Almeida CG et al (2005) Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci 8:1051–1058

30. Parameshwaran K, Dhanasekaran M, Suppiramaniam V (2008) Amyloid beta peptides and glutamatergic synaptic dysregulation. Exp Neurol 210:7–13

31. Di X, Yan J, Zhao Y et al (2010) L-Theanine protects the APP (Swedish mutation) transgenic SH-SY5Y cell against glutamate-induced excitotoxicity via inhibition of the NMDA receptor pathway. Neuroscience 168:778–786

32. Siamwala JH, Dias PM, Majumder S et al (2013) L-Theanine promotes nitric oxide production in endothelial cells through eNOS phosphorylation. J Nutr Biochem 24:595–605

33. Kim TI, Lee YK, Park SG et al (2009) L-Theanine, an amino acid in green tea, attenuates beta-amyloid-induced cognitive dysfunction and neurotoxicity: reduction in oxidative damage and inactivation of ERK/p38 kinase and NF-kappaB pathways. Free Radic Biol Med 47:1601–1610

34. Kakuda T (2011) Neuroprotective effects of theanine and its preventive effects on cognitive dysfunction. Pharmacol Res 64:162–168

35. Unno K, Fujitani K, Takamori N et al (2011) Theanine intake improves the shortened lifespan, cognitive dysfunction and behavioural depression that are induced by chronic psychosocial stress in mice. Free Radic Res 45:966–974

36. Gong Y, Luo Y, Huang JA et al (2012) Theanine improves stress resistance in Caenorhabditis elegans. J Funct Foods 4:988–993

37. Gu D, Kelly TN, Wu X et al (2009) Mortality attributable to smoking in China. N Engl J Med 360:150–159

38. Framework Convention Alliance. FCTC Alliance Bulletin. Issue 1–71. http://fctc.org/docs/bulletin/fca-bulletin-071.pdf

39. World Health Organization (2007) Updated status of the WHO framework convention on tobacco control. http://www.who.int/tobacco/framework/

40. Ray R, Schnoll RA, Lerman C (2009) Nicotine dependence: biology, behavior, and treatment. Annu Rev Med 60:247–260

41. Rigotti NA (2002) Clinical practice. Treatment of tobacco use and dependence. N Engl J Med 346:506–512

42. Tapper AR, McKinney SL, Nashmi R et al (2004) Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization. Science 306:1029–1032

43. Picciotto MR, Kenny PJ (2013) Molecular mechanisms underlying behaviors related to nicotine addiction. Cold Spring Harb Perspect Med 3:a012112

44. Bencherif M, Fowler K, Lukas RJ et al (1995) Mechanisms of up-regulation of neuronal nicotinic acetylcholine receptors in clonal cell lines and primary cultures of fetal rat brain. J Pharmacol Exp Ther 275:987–994

45. Breese CR, Marks MJ, Logel J et al (1997) Effect of smoking history on [3H] nicotine binding in human postmortem brain. J Pharmacol Exp Ther 282:7–13

46. Besson M, Granon S, Mameli-Engvall M et al (2007) Long-term effects of chronic nicotine exposure on brain nicotinic receptors. Proc Natl Acad Sci USA 104:8155–8160

47. Garwood CL, Potts LA (2007) Emerging pharmacotherapies for smoking cessation. Am J Health Syst Pharm 64:1693–1698

48. Dwoskin LP, Smith AM, Wooters TE et al (2009) Nicotinic receptor-based therapeutics and candidates for smoking cessation. Biochem Pharmacol 78:732–743

49. Mansvelder HD, Keath JR, McGehee DS (2002) Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 33:905–919

50. Schoffelmeer AN, De Vries TJ, Wardeh G et al (2002) Psychostimulant-induced behavioral sensitization depends on nicotinic receptor activation. J Neurosci 22:3269–3276

51. Panagis G, Nisell M, Nomikos GG et al (1996) Nicotine injections into the ventral tegmental area increase locomotion and Fos-like immunoreactivity in the nucleus accumbens of the rat. Brain Res 730:133–142

52. Shram MJ, Funk D, Li Z et al (2007) Acute nicotine enhances c-fos mRNA expression differentially in reward-related substrates of adolescent and adult rat brain. Neurosci Lett 418:286–291